Latest News on A

Financial News Based On Company


Advertisement
Advertisement

GEHC or A: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2730488/gehc-or-a-which-is-the-better-value-stock-right-now
GEHC vs. A: Which Stock Is the Better Value Option?

Rockwell Medical ( RMTI ) Reports Q2 Loss, Tops Revenue Estimates

https://www.zacks.com/stock/news/2711510/rockwell-medical-rmti-reports-q2-loss-tops-revenue-estimates
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 0.00% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Sanara MedTech Inc. ( SMTI ) Reports Q2 Loss, Tops Revenue Estimates

https://www.zacks.com/stock/news/2706733/sanara-medtech-inc-smti-reports-q2-loss-tops-revenue-estimates
Sanara MedTech (SMTI) delivered earnings and revenue surprises of +30.30% and +1.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights

https://www.benzinga.com/pressreleases/25/08/g46999209/baculovirus-expression-system-market-poised-for-significant-growth-estimate-to-hit-usd-781-8-milli
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.

TerrAscend Corp. ( TSNDF ) Reports Q2 Loss, Beats Revenue Estimates

https://www.zacks.com/stock/news/2680611/terrascend-corp-tsndf-reports-q2-loss-beats-revenue-estimates
TerrAscend Corp. (TSNDF) delivered earnings and revenue surprises of -50.00% and +0.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Would You Ride in a Flying Car? This Company Could Make It a Reality ( and Yes, It's Publicly Traded ) .

https://www.fool.com/investing/2025/08/02/would-you-ride-in-a-flying-car-this-company-could/
This aviation pioneer is poised to potentially usher in transportation's next major milestone.

[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )

https://www.benzinga.com/pressreleases/25/07/g46615291/latest-global-crispr-gene-editing-market-sizeshare-worth-usd-12-6-billion-by-2034-at-a-13-01-cagr-
Austin, TX, USA, July 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "CRISPR Gene Editing Market Size, Trends and Insights By Product ( Kits and Reagents, Services ) , By Gene Editing Modality ( Ex-Vivo Editing, In-Vivo Editing ) , By Technology ...

P/E Ratio Insights for Agilent Technologies - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/news/25/07/46499349/pe-ratio-insights-for-agilent-technologies
In the current session, Agilent Technologies Inc. A is trading at $115.19, after a 1.01% drop. Over the past month, the stock fell by 1.07%, and in the past year, by 14.32%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ...

What's Driving the Market Sentiment Around Agilent Technologies? - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/short-sellers/25/07/46401990/whats-driving-the-market-sentiment-around-agilent-technologies
Agilent Technologies's A short percent of float has fallen 18.29% since its last report. The company recently reported that it has 3.35 million shares sold short, which is 1.34% of all regular shares that are available for trading.

In Situ Hybridization Market is expected to generate a revenue of USD 3.38 Billion by 2031, Globally, at 8.97% CAGR: Verified Market Research®

https://www.benzinga.com/pressreleases/25/07/g46392915/in-situ-hybridization-market-is-expected-to-generate-a-revenue-of-usd-3-38-billion-by-2031-globall
Lewes, Delaware, July 14, 2025 ( GLOBE NEWSWIRE ) -- The Global In Situ Hybridization Market Size is projected to grow at a CAGR of 8.97% from 2024 to 2031, according to a new report published by Verified Market Research®.
Advertisement

Here's How Much a $1000 Investment in Agilent Technologies Made 10 Years Ago Would Be Worth Today

https://www.zacks.com/stock/news/2579421/heres-how-much-a-1000-investment-in-agilent-technologies-made-10-years-ago-would-be-worth-today
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Do Options Traders Know Something About Agilent Technologies Stock We Don't?

https://www.zacks.com/stock/news/2565863/do-options-traders-know-something-about-agilent-technologies-stock-we-dont
Investors need to pay close attention to Agilent Technologies stock based on the movements in the options market lately.

's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Alcoa ( NYSE:AA ) , Agilent Technologies ( NYSE:A )

https://www.benzinga.com/trading-ideas/long-ideas/25/06/46157351/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-ye
The Benzinga Stock Whisper Index highlights five stocks each week seeing more interest from readers than normal. Tariffs could impact one of the company's on the list in their next financial results. Geopolitical tensions, Fed uncertainty, and fast-moving headlines are driving July volatility.

Why Is Agilent ( A ) Up 5.4% Since Last Earnings Report?

https://www.zacks.com/stock/news/2556208/why-is-agilent-a-up-54-since-last-earnings-report
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Laboratory Information Management System Market worth US$5.19 billion by 2030 with 12.5% CAGR | MarketsandMarkets™.

https://www.benzinga.com/pressreleases/25/06/g46137380/laboratory-information-management-system-market-worth-us-5-19-billion-by-2030-with-12-5-cagr-marke
Delray Beach, FL, June 27, 2025 ( GLOBE NEWSWIRE ) -- The global laboratory information management system market, valued at US$2.54 billion in 2024, stood at US$2.88 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation ...
Advertisement

Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors

https://www.benzinga.com/pressreleases/25/06/g46092436/arbor-biotechnologies-appoints-mikael-dolsten-m-d-ph-d-to-board-of-directors
CAMBRIDGE, Mass., June 25, 2025 ( GLOBE NEWSWIRE ) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of Directors.

Looking Into Agilent Technologies's Recent Short Interest - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/short-sellers/25/06/46082508/looking-into-agilent-technologiess-recent-short-interest
Agilent Technologies's A short percent of float has fallen 5.17% since its last report. The company recently reported that it has 4.14 million shares sold short, which is 1.65% of all regular shares that are available for trading.

Here's How Much You'd Have If You Invested $1000 in Agilent Technologies a Decade Ago

https://www.zacks.com/stock/news/2514647/heres-how-much-youd-have-if-you-invested-1000-in-agilent-technologies-a-decade-ago
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board

https://www.benzinga.com/pressreleases/25/06/g45990993/rarecells-inc-appoints-dr-rita-shaknovich-to-scientific-advisory-board
NEW YORK and PARIS, June 18, 2025 ( GLOBE NEWSWIRE ) -- Rarecells, Inc., a leader in liquid biopsy technology, is pleased to announce the appointment of Dr. Rita Shaknovich to its Scientific Advisory Board. Dr. Shaknovich brings over 20 years of leadership experience across private industry and ...

Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.

https://www.benzinga.com/pressreleases/25/06/g45881467/genomics-market-to-hit-us-66-8-billion-by-2029-with-9-4-cagr-marketsandmarkets
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
Advertisement

Don't Overlook Agilent ( A ) International Revenue Trends While Assessing the Stock

https://www.zacks.com/stock/news/2480129/dont-overlook-agilent-a-international-revenue-trends-while-assessing-the-stock
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Company News for May 30, 2025

https://www.zacks.com/stock/news/2479411/company-news-for-may-30-2025
Companies in The News Are: A, ...

Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise

https://www.zacks.com/stock/news/2478958/agilent-q2-earnings-beat-estimates-revenues-up-yy-shares-rise
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.

Veeva Systems, e.l.f. Beauty, C3.ai, BRP And Other Big Stocks Moving Higher On Thursday - Agilent Technologies ( NYSE:A ) , C3.ai ( NYSE:AI )

https://www.benzinga.com/25/05/45671619/veeva-systems-e-l-f-beauty-c3-ai-brp-and-other-big-stocks-moving-higher-on-thursday
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 100 points on Thursday. Shares of Veeva Systems Inc. VEEV rose sharply during Thursday's session following strong quarterly results. The company reported adjusted earnings per share of $1.97, beating the analyst consensus ...

Agilent Braces For Potential US-EU Tariff Hike, Maintains Annual Outlook - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/general/health-care/25/05/45669099/agilent-braces-for-potential-us-eu-tariff-hike-maintains-annual-outlook
Q2 adjusted EPS rose to $1.31 vs. $1.26 consensus, up from $1.22 a year ago. Agilent ups FY25 revenue forecast to $6.73 billion-$6.81 billion, from prior $6.68 billion-$6.76 billion. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for ...
Advertisement

Agilent Technologies ( A ) Q2 Earnings and Revenues Top Estimates

https://www.zacks.com/stock/news/2478547/agilent-technologies-a-q2-earnings-and-revenues-top-estimates
Agilent (A) delivered earnings and revenue surprises of 3.97% and 2.64%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?

Judy Brown Of Agilent Technologies Shows Optimism, Buys $182K In Stock - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/news/25/05/45589861/judy-brown-of-agilent-technologies-shows-optimism-buys-182k-in-stock
Judy Brown, Board Member at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Brown made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.

Positive Signal: Pascal Soriot Shows Faith, Buying $182K In Agilent Technologies Stock - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/news/25/05/45589854/positive-signal-pascal-soriot-shows-faith-buying-182k-in-agilent-technologies-stock
Pascal Soriot, Director at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.

Curious about Agilent ( A ) Q2 Performance? Explore Wall Street Estimates for Key Metrics

https://www.zacks.com/stock/news/2475896/curious-about-agilent-a-q2-performance-explore-wall-street-estimates-for-key-metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.

Digital PCR and Real-Time PCR Market Size Worth USD 17.54 billion by 2031 at 9.1% CAGR | The Insight Partners

https://www.benzinga.com/pressreleases/25/05/g45493282/digital-pcr-and-real-time-pcr-market-size-worth-usd-17-54-billion-by-2031-at-9-1-cagr-the-insight-
US & Canada, May 19, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global digital PCR and real-time PCR market is witnessing substantial growth with the surging incidence of genetic and infectious diseases and rising investments in gene ...
Advertisement

Sanara MedTech Inc. ( SMTI ) Reports Q1 Loss, Tops Revenue Estimates

https://www.zacks.com/stock/news/2470217/sanara-medtech-inc-smti-reports-q1-loss-tops-revenue-estimates
Sanara MedTech (SMTI) delivered earnings and revenue surprises of -32.26% and 5.32%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

How Do Investors Really Feel About Agilent Technologies? - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/short-sellers/25/05/45383604/how-do-investors-really-feel-about-agilent-technologies
Agilent Technologies's A short percent of float has risen 17.01% since its last report. The company recently reported that it has 4.32 million shares sold short, which is 1.72% of all regular shares that are available for trading.

Zimmer Biomet ( ZBH ) Surpasses Q1 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2461701/zimmer-biomet-zbh-surpasses-q1-earnings-and-revenue-estimates
Zimmer (ZBH) delivered earnings and revenue surprises of 2.84% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Will Agilent ( A ) Beat Estimates Again in Its Next Earnings Report?

https://www.zacks.com/stock/news/2461472/will-agilent-a-beat-estimates-again-in-its-next-earnings-report
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Strong Segmental Performance to Drive Stryker's Q1 Earnings?

https://www.zacks.com/stock/news/2459132/strong-segmental-performance-to-drive-strykers-q1-earnings
SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Advertisement

DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact?

https://www.zacks.com/stock/news/2458026/dxcm-q1-earnings-to-reflect-us-coverage-expansion-stelo-impact
DexCom Q1 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

https://www.zacks.com/stock/news/2457607/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Will BAX's Q1 Earnings Improve Following Transformation Completion?

https://www.zacks.com/stock/news/2457213/will-baxs-q1-earnings-improve-following-transformation-completion
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.

Are Options Traders Betting on a Big Move in Agilent Technologies Stock?

https://www.zacks.com/stock/news/2457176/are-options-traders-betting-on-a-big-move-in-agilent-technologies-stock
Investors need to pay close attention to A stock based on the movements in the options market lately.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

https://www.zacks.com/stock/news/2456580/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Advertisement

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

https://www.zacks.com/stock/news/2447202/looking-for-stocks-with-positive-earnings-momentum-check-out-these-2-medical-names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029

https://www.benzinga.com/pressreleases/25/04/g44651857/bioprocess-optimization-and-digital-bio-manufacturing-market-forecast-2029
Boston, April 04, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, "Bioprocess Optimization and Digital Bio-manufacturing: Global Markets" is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a compound annual growth rate ( CAGR ) of ...

Agilent ( A ) Down 6.4% Since Last Earnings Report: Can It Rebound?

https://www.zacks.com/stock/news/2436977/agilent-a-down-64-since-last-earnings-report-can-it-rebound
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine

https://www.benzinga.com/pressreleases/25/03/g44396983/proscia-raises-50m-to-advance-ai-driven-pathology-and-deliver-the-future-of-precision-medicine
Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment Funding led by global software investor Insight Partners comes as the surge in cancer cases compounds the impact of the shrinking ...

Director At Agilent Technologies Buys $220K of Stock - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/news/25/03/44379082/director-at-agilent-technologies-buys-220k-of-stock
Disclosed in the latest SEC filing, a significant insider purchase on March 18, involves Mala Anand, Director at Agilent Technologies A. What Happened: Anand's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, involves purchasing 1,819 shares ...
Advertisement

Agilent Technologies Board Member Trades $318K In Company Stock - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/news/25/03/44379078/agilent-technologies-board-member-trades-318k-in-company-stock
A notable insider purchase on March 18, was reported by Otis W Brawley, Board Member at Agilent Technologies A, based on the most recent SEC filing. What Happened: Brawley's recent move, as outlined in a Form 4 filing with the U.S.

Agilent Technologies Board Member Trades $220K In Company Stock - Agilent Technologies ( NYSE:A )

https://www.benzinga.com/insights/news/25/03/44379074/agilent-technologies-board-member-trades-220k-in-company-stock
In a recent SEC filing, it was revealed that HEIDI FIELDS, Board Member at Agilent Technologies A, made a noteworthy insider purchase on March 18,. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that FIELDS purchased 1,819 shares of Agilent ...

Should You Invest in the First Trust Water ETF ( FIW ) ?

https://www.zacks.com/stock/news/2430534/should-you-invest-in-the-first-trust-water-etf-fiw
Sector ETF report for ...

Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035

https://www.benzinga.com/pressreleases/25/03/g44266198/breast-cancer-diagnostics-market-set-for-6-9-cagr-growth-projected-to-hit-usd-12-45-billion-by-203
Rockville, MD, March 11, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics market is estimated to reach a valuation of USD 6,389 million in 2025 and is expected to grow at a CAGR of 6.9% during the ...

$6.7 Billion Laboratory Consumables Market by 2034: Growth in Germany, Belgium, and Netherlands Fueled by Increasing R&D Investments - Analysis by TMR

https://www.benzinga.com/pressreleases/25/03/g44244279/6-7-billion-laboratory-consumables-market-by-2034-growth-in-germany-belgium-and-netherlands-fueled
Wilmington, Delaware, Transparency Market Research Inc. -, March 11, 2025 ( GLOBE NEWSWIRE ) -- The laboratory consumables market in Germany, Belgium, and the Netherlands is witnessing significant growth, fueled by rising R&D investments, technological advancements, and expanding biotech ...
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion